The ceramide-based Coronary Event Risk Test (CERT) predicts cardiovascular mortality in cardiovascular disease patients with type 2 diabetes mellitus as well as in those without diabetes
Event:
ESC Congress 2019
Topic:
Biomarkers
Session:
Diabetes and the heart